These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2515609)

  • 1. Fibrinolytic response to venous occlusion for 10 and 20 minutes in healthy subjects and in patients with deep vein thrombosis.
    Petäjä J
    Thromb Res; 1989 Oct; 56(2):251-63. PubMed ID: 2515609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial clustering of defective release of t-PA.
    Petäjä J; Rasi V; Vahtera E; Myllylä G
    Br J Haematol; 1991 Oct; 79(2):291-5. PubMed ID: 1958488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.
    Nguyen G; Horellou MH; Kruithof EK; Conard J; Samama MM
    Blood; 1988 Aug; 72(2):601-5. PubMed ID: 3135860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic response in normal subjects to venous occlusion and DDAVP infusion.
    Cugno M; Uziel L; Fabrizi I; Bottasso B; Maggiolini F; Agostoni A
    Thromb Res; 1989 Dec; 56(5):625-34. PubMed ID: 2516662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The release of plasminogen activators (t-PA and u-PA) and plasminogen activator inhibitor (PAI-1) after venous stasis.
    Falkon L; Garí M; Borrell M; Fontcuberta J
    Blood Coagul Fibrinolysis; 1992 Feb; 3(1):33-8. PubMed ID: 1623118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D
    Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
    Opatrný K; Vít L; Opatrná S; Sulková S; Bodláková B
    Cas Lek Cesk; 1994 May; 133(11):346-9. PubMed ID: 8004664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.
    Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Shen C; Newcomer LM; Goldhaber SZ; Hennekens CH
    Circulation; 1992 May; 85(5):1822-7. PubMed ID: 1572039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
    Francis RB; McGehee WG; Feinstein DI
    Thromb Haemost; 1988 Jun; 59(3):412-4. PubMed ID: 3142079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release.
    Levi M; Lensing AW; Büller HR; Prandoni P; Dooijewaard G; Cuppini S; ten Cate JW
    Thromb Haemost; 1991 Oct; 66(4):426-9. PubMed ID: 1796391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypofibrinolysis and venous thrombosis.
    Petäjä J; Rasi V; Myllylä G; Vahtera E; Hallman H
    Br J Haematol; 1989 Mar; 71(3):393-8. PubMed ID: 2495018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis.
    Stegnar M; Peternel P; Keber D; Vene N
    Thromb Res; 1991 Nov; 64(4):445-53. PubMed ID: 1788830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standard heparin but not LMW heparin induces a concomitant increase of t-PA and PAI-1 without modification of global fibrinolysis: study after 60 days treatment.
    Vergnes C; Manciet G; Bourdenx V; Roudaut MF; Lacombe F; Boisseau MR
    Thromb Res; 1991 Sep; 63(5):521-30. PubMed ID: 1661447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
    Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased tissue-plasminogen activator (t-PA) levels in patients under oral anticoagulant therapy.
    Grulich-Henn J; Loechelt K; Speiser W; Müller-Berghaus G
    Blut; 1989 Jan; 58(1):39-43. PubMed ID: 2492837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator release in chronic venous hypertension due to heart failure.
    Keber I; Keber D; Stegnar M; Vene N
    Thromb Haemost; 1992 Sep; 68(3):321-4. PubMed ID: 1440498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis and spinal injury. Relationship to post-traumatic deep vein thrombosis.
    Petäjä J; Myllynen P; Rokkanen P; Nokelainen M
    Acta Chir Scand; 1989; 155(4-5):241-6. PubMed ID: 2508383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
    Stegnar M; Mavri A
    Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.